ACREAGE HLDGS INC.CL.D SV
Acreage Holdings, Inc. operates in cannabis industry in the United States. It cultivates and processes cannabis plants; manufactures branded consumer products; distributes cannabis flower and manufactured products; and retails dosable cannabis products to consumers. The company serves medical and adult recreational use customers in Connecticut, Illinois, Maine, Massachusetts, New Jersey, New York… Read more
ACREAGE HLDGS INC.CL.D SV (0VZ2) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ACREAGE HLDGS INC.CL.D SV (0VZ2) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ACREAGE HLDGS INC.CL.D SV - Net Assets Trend (None–None)
This chart illustrates how ACREAGE HLDGS INC.CL.D SV's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ACREAGE HLDGS INC.CL.D SV (None–None)
The table below shows the annual net assets of ACREAGE HLDGS INC.CL.D SV from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ACREAGE HLDGS INC.CL.D SV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ACREAGE HLDGS INC.CL.D SV Competitors by Market Cap
The table below lists competitors of ACREAGE HLDGS INC.CL.D SV ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Misr Hotels
EGX:MHOT
|
$4.68K |
|
Dam Phu My Packaging JSC
VN:PMP
|
$4.69K |
|
AMA GRP
BE:KC7
|
$4.69K |
|
Ngan Son JSC
VN:NST
|
$4.69K |
|
Affinity Gold Corp
PINK:AFYG
|
$4.68K |
|
I-Minerals Inc
PINK:IMAHF
|
$4.68K |
|
BluSky AI, Inc.
PINK:IMIID
|
$4.68K |
|
Small Business Development Group Inc
PINK:SBDG
|
$4.67K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ACREAGE HLDGS INC.CL.D SV's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ACREAGE HLDGS INC.CL.D SV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ACREAGE HLDGS INC.CL.D SV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ACREAGE HLDGS INC.CL.D SV's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ACREAGE HLDGS INC.CL.D SV (0VZ2) | €- | N/A | N/A | $4.68K |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |